Ney; Hartmut

Patent Applications and Registrations

Patent applications and USPTO patent grants for Ney; Hartmut.The latest application filed is for "oral dosage form containing a pde 4 inhibitor as an active ingredient and polyvinylpyrrolidon as excipient".

Company Profile

0.16.23

Ney; Hartmut - Constance DE
Ney; Hartmut - Konstanz DE
Ney; Hartmut - US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Oral dosage form containing a PDE 4 inhibitor as an active ingredient and polyvinylpyrrolidon as excipient Grant 9,468,598 - Dietrich , et al. October 18, 2	2016-10-18
Oral Dosage Form Containing A PDE 4 Inhibitor as an Active Ingredient and Polyvinylpyrrolidon as Excipient App 20150290180 - Dietrich; Rango ; et al.	2015-10-15
Oral Dosage Form Containing A PDE 4 Inhibitor as an Active Ingredient and Polyvinylpyrrolidon as Excipient App 20150290179 - Dietrich; Rango ; et al.	2015-10-15
Oral Dosage Form Containing A PDE 4 Inhibitor as an Active Ingredient and Polyvinylpyrrolidon as Excipient App 20150290178 - Dietrich; Rango ; et al.	2015-10-15
Dosage form containing (S)-pantoprazole as active ingredient Grant 8,758,817 - Dietrich , et al. June 24, 2	2014-06-24
Dosage form containing pantoprazole as active ingredient Grant 8,703,192 - Anstett-Klein , et al. April 22, 2	2014-04-22
Oral Dosage Form Containing A Pde 4 Inhibitor As An Active Ingredient And Polyvinylpyrrolidon As Excipient App 20140031396 - Dietrich; Rango ; et al.	2014-01-30
Oral Dosage Form Containing A Pde 4 Inhibitor As An Active Ingredient And Polyvinylpyrrolidon As Excipient App 20140031397 - Dietrich; Rango ; et al.	2014-01-30
Oral Dosage Form Containing A Pde 4 Inhibitor As An Active Ingredient And Polyvinylpyrrolidon As Excipient App 20130345265 - Dietrich; Rango ; et al.	2013-12-26
Oral administration form for pyridin-2-ylmethylsulfinyl-1H benzimidazoles Grant 8,465,767 - Dietrich , et al. June 18, 2	2013-06-18
Oral Dosage Form Containing A Pde 4 Inhibitor As An Active Ingredient And Polyvinylpyrrolidon As Excipient App 20130131123 - DIETRICH; Rango ; et al.	2013-05-23
Oral dosage form containing a PDE 4 inhibitor as an active ingredient and polyvinylpyrrolidone as excipient Grant 8,431,154 - Dietrich , et al. April 30, 2	2013-04-30
Oral Dosage Form Containing A PDE 4 Inhibitor As An Active Ingredient And Polyvinylpyrrolidone As Excipient App 20110251244 - Dietrich; Rango ; et al.	2011-10-13
Dosage Form Containing (s)-pantoprazole As Active Ingredient App 20110171303 - DIETRICH; Rango ; et al.	2011-07-14
Pharmaceutical preparation comprising an active dispersed on a matrix Grant 7,951,398 - Dietrich , et al. May 31, 2	2011-05-31
Oral dosage form containing a PDE 4 inhibitor as an active ingredient and polyvinylpyrrolidon as excipient Grant 7,951,397 - Dietrich , et al. May 31, 2	2011-05-31
Oral dosage form containing a pde 4 inhibitor as an active ingredient and polyvinylpyrrolidon as excipient App 20110060016 - Dietrich; Rango ; et al.	2011-03-10
Dosage form containing pantoprazole as active ingredient App 20090208571 - Dietrich; Rango ; et al.	2009-08-20
Oral administration form for pyridin-2-ylmethylsulfinyl-1H benzimidazoles App 20080226712 - Dietrich; Rango ; et al.	2008-09-18
Oral administration form for pyridin-2-ylmethylsulfinyl-1H-benzimidazoles Grant 7,402,321 - Dietrich , et al. July 22, 2	2008-07-22
Oral Pharmaceutical Preparation for Proton Pump Antagonists App 20080102133 - Brueck-Scheffler; Antje ; et al.	2008-05-01
Oral Pharmaceutical Preparation Comprising a Proton Pump Antagonist and a Basic Excipient App 20080050428 - Ney; Hartmut ; et al.	2008-02-28
Pharmaceutical preparation comprising an active dispersed on a matrix App 20070122474 - Dietrich; Rango ; et al.	2007-05-31
Pharmaceutical preparation comprising an active dispersed on a matrix Grant 7,175,854 - Dietrich , et al. February 13, 2	2007-02-13
Rapidly disintegrating tablet comprising an acid-labile active ingredient Grant 7,147,869 - Dietrich , et al. December 12, 2	2006-12-12
Oral dosage form containing a PDE 4 inhibitor as an active ingredient and polyvinylpyrrolidon as excipient App 20060269600 - Dietrich; Rango ; et al.	2006-11-30
Oral administration form for pyridin-2-ylmethysulfinyl-1h-bezimidazoles App 20060263426 - Dietrich; Rango ; et al.	2006-11-23
Dosage form containing (s)-pantoprazole as active ingredient App 20060216346 - Dietrich; Rango ; et al.	2006-09-28
Oral pharmaceutical preparation for proton pump antagonists App 20060204568 - Dietrich; Rango ; et al.	2006-09-14
Oral administration form for pyridin-2-ylmethylsulfinyl-1H-benzimidazoles Grant 7,041,313 - Dietrich , et al. May 9, 2	2006-05-09
Oral dosage form containing a pde 4 inhibitor as an active ingredient and polyvinylpyrrolidon as excipient App 20050159492 - Dietrich, Rango ; et al.	2005-07-21
Rapidly disintegrating tablet comprising an acid-labile active ingredient App 20040110661 - Dietrich, Rango ; et al.	2004-06-10
Pharmaceutical preparation comprising an active dispersed on a matrix App 20040058896 - Dietrich, Rango ; et al.	2004-03-25
Oral-administration forms of a medicament containing pantoprazol Grant 5,997,903 - Dietrich , et al. December 7, 1	1999-12-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.